Fool - Investing News·3 days ago
State Street or iShares: Which Consumer Staples ETF Offers Better Value?Compare sector focus, portfolio concentration, and diversification strategies to see how these funds stack up for defensive investors.
Consumer Staples Select Sector SPDR Fund(XLP)Earnings, Financials & Key Ratios
XLP•ARCA
$84.86
Price updated Jul 7, 2026
XLP Price & Volume
Consumer Staples Select Sector SPDR Fund (XLP) stock price & volume — 10-year historical chart
Loading chart...
Concentrated Staples Exposure Masks Idiosyncratic Sector Risks
Investment Thesis • Updated N/A
VerdictNeutral: While the fund provides efficient market access
Growth:Stable
Profitability:Strong
Financial:Healthy
Cash Flow:Stable
Primary Risk:Concentration in mega-cap holdings
Key Thesis Takeaways
- XLP offers a defensive, low-cost vehicle for sector exposure, yet investors should monitor the significant concentration risk where the top five holdings represent over 50% of the fund's total weight.
- While the 9 basis point management fee ensures structural cost efficiency, the underlying constituents' high debt-to-EBITDA levels may introduce volatility that contradicts the fund's defensive mandate.
- Long-term performance remains heavily reliant on the dividend policies of these mega-cap staples, necessitating a cautious approach to potential regulatory or product liability shocks.
Verdict Logic
the concentration of over 50% of assets in the top five holdings warrants caution regarding idiosyncratic sector risks.
Latest XLP News
Recent stock market news and headlines for Consumer Staples Select Sector SPDR Fund (XLP)
24/7 Wall Street·6 days ago
XLP's 2.6% Yield Holds Firm as Retail Sales Hit 12-Month HighThe Consumer Staples Select Sector SPDR Fund (NYSEARCA:XLP) is the default ticker investors reach for when they want a slice of the cereal aisle, the laundry detergent shelf, and the checkout counter inside one wrapper.
Business Wire·Jun 22, 2026
GondolaBio Announces Positive Phase 2a Results Demonstrating 79% Plasma Protoporphyrin IX Reduction and Disease-Modifying Potential of PORT-77 for Erythropoietic ProtoporphyriaPALO ALTO, Calif.--(BUSINESS WIRE)--GondolaBio, a clinical-stage biopharmaceutical company developing novel medicines for patients living with genetic diseases, on behalf of its affiliate Portal Therapeutics, today announced positive data from its Phase 2a GATEWAY trial of PORT-77 in patients with erythropoietic protoporphyria (EPP). PORT-77 is a novel investigational oral, small molecule ABCG2 inhibitor designed to treat EPP and X-linked protoporphyria (XLP), two rare genetic disorders charact.
The Motley Fool·Jun 21, 2026
XLP vs. VDC: Which Consumer Staples ETF Is the Better Buy?The State Street Consumer Staples Select Sector SPDR ETF (XLP) offers a lower expense ratio and higher dividend yield than the Vanguard Consumer Staples ETF (VDC). VDC provides more diversified exposure with 103 holdings compared to XLP's 36 positions.
Fool - Investing News·Jun 17, 2026
Fidelity vs. State Street: Which Consumer Staples ETF Stands Out?These two low-cost defensive ETFs share many similarities, but one is clearly a more attractive buy.
Get notified when XLP posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.